NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,292,626 | +194.1% | 32,325 | +191.4% | 0.04% | +127.8% |
Q2 2023 | $1,119,496 | +34.6% | 11,094 | +22.7% | 0.02% | +28.6% |
Q1 2023 | $831,772 | -38.4% | 9,041 | -39.2% | 0.01% | -46.2% |
Q4 2022 | $1,349,586 | +18.4% | 14,876 | -0.9% | 0.03% | 0.0% |
Q3 2022 | $1,140,000 | -24.1% | 15,007 | -15.4% | 0.03% | -18.8% |
Q2 2022 | $1,501,000 | -47.0% | 17,736 | -45.0% | 0.03% | -17.9% |
Q1 2022 | $2,832,000 | +154.7% | 32,271 | +153.9% | 0.04% | +34.5% |
Q4 2021 | $1,112,000 | +1.7% | 12,710 | -4.9% | 0.03% | +7.4% |
Q3 2021 | $1,093,000 | -15.5% | 13,363 | -5.7% | 0.03% | -41.3% |
Q2 2021 | $1,293,000 | +129.7% | 14,167 | +115.6% | 0.05% | +31.4% |
Q1 2021 | $563,000 | -54.3% | 6,571 | -49.6% | 0.04% | -58.3% |
Q4 2020 | $1,232,000 | +27.1% | 13,033 | +17.0% | 0.08% | -10.6% |
Q3 2020 | $969,000 | -11.7% | 11,144 | -11.5% | 0.09% | -14.5% |
Q2 2020 | $1,098,000 | +32.9% | 12,599 | +25.5% | 0.11% | -16.7% |
Q1 2020 | $826,000 | – | 10,037 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |